ACOG Alpha Cognition Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ACOG

Price (delayed)

$5.9

Market cap

$128.47M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.34

Enterprise value

$74.16M

?
Relative Growth: Rel. Growth: 33
Relative Strength: Rel. Strength: 31
Relative Valuation: Rel. Valuation: 9
Relative Profitability: Rel. Profitability: 18

The Company is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease (“Alzheimer’s disease” or “AD”), for which there are limited or ...

Highlights
The gross margin has grown by 18% YoY and by 3.8% from the previous quarter
ACOG's gross profit is up by 10% QoQ
Alpha Cognition's equity has increased by 41% YoY but it has decreased by 8% from the previous quarter
The quick ratio has grown by 39% from the previous quarter but it has contracted by 35% YoY
The net income has dropped by 118% year-on-year and by 22% since the previous quarter
ACOG's EPS is down by 15% since the previous quarter and by 3.1% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: https://www.alphacognition.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of ACOG

ACOG stock price

How has the Alpha Cognition stock price performed over time
Intraday
-2.96%
1 week
-0.67%
1 month
-2.48%
1 year
-38.38%
YTD
-9.23%
QTD
7.47%

Financial performance

How have Alpha Cognition's revenue and profit performed over time
Revenue
$10.83M
Gross profit
$9.14M
Operating income
-$27.07M
Net income
-$25.14M
Gross margin
84.4%
Net margin
-232.2%
The operating income has plunged by 146% YoY and by 19% from the previous quarter
The net income has dropped by 118% year-on-year and by 22% since the previous quarter
ACOG's net margin is up by 41% year-on-year but it is down by 15% since the previous quarter
Alpha Cognition's operating margin has increased by 33% YoY but it has decreased by 13% from the previous quarter

Price vs fundamentals

How does ACOG's price correlate with its fundamentals

Growth

What is Alpha Cognition's growth rate over time

Valuation

What is Alpha Cognition stock price valuation
P/E
N/A
P/B
2.24
P/S
11.86
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.85
ACOG's EPS is down by 15% since the previous quarter and by 3.1% year-on-year
Alpha Cognition's equity has increased by 41% YoY but it has decreased by 8% from the previous quarter
The P/B is 23% less than the last 4 quarters average of 3.0
The P/S is 29% below the last 4 quarters average of 17.3
ACOG's revenue is up by 6% since the previous quarter

Efficiency

How efficient is Alpha Cognition business performance
ACOG's return on sales is up by 43% year-on-year but it is down by 11% since the previous quarter
Alpha Cognition's ROIC has increased by 40% from the previous quarter
The return on equity has increased by 11% year-on-year but it has declined by 11% since the previous quarter
ACOG's ROA is down by 11% since the previous quarter but it is up by 3.5% year-on-year

Dividends

What is ACOG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ACOG.

Financial health

How did Alpha Cognition financials performed over time
Alpha Cognition's total liabilities has soared by 51% YoY but it has decreased by 31% from the previous quarter
Alpha Cognition's current ratio has increased by 46% from the previous quarter but it has decreased by 26% YoY
ACOG's debt is 100% smaller than its equity
Alpha Cognition's equity has increased by 41% YoY but it has decreased by 8% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.